Repository logo
 

Shortening the diagnostic odyssey-the impact of whole genome sequencing in the NHS.

Accepted version
Peer-reviewed

No Thumbnail Available

Type

Article

Change log

Authors

Chinnery, Patrick F 

Abstract

I met my first patient with suspected mitochondrial disease in 1995 as a junior neurology trainee in Newcastle upon Tyne. At the time, mitochondrial disorders were thought to be exceptionally rare, with the first genetically defined causes reported only seven years earlier.1 2 Most genetic investigations were carried out in unregulated university laboratories located in a small number of locations worldwide, and referrals were mainly from tertiary centres after a protracted series of clinical opinions and investigations. Many clinicians had not even heard of mitochondrial diseases

Description

Keywords

Genetic Testing, Health Care Costs, Humans, Mitochondrial Diseases, State Medicine, Time Factors, United Kingdom, Whole Genome Sequencing

Journal Title

BMJ

Conference Name

Journal ISSN

0959-8146
1756-1833

Volume Title

375

Publisher

BMJ
Sponsorship
Cambridge University Hospitals NHS Foundation Trust (CUH) (146281)
Wellcome Trust (212219/Z/18/Z)